162 related articles for article (PubMed ID: 1690279)
41. Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis.
Giannini EG; Marenco S; Borgonovo G; Savarino V; Farinati F; Del Poggio P; Rapaccini GL; Anna Di Nolfo M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Hepatology; 2012 Oct; 56(4):1371-9. PubMed ID: 22535689
[TBL] [Abstract][Full Text] [Related]
42. Two-site enzyme immunoassay for alpha-fetoprotein involving column chromatography.
Yamamoto R; Kimura S; Matsuura A; Fukuda Y; Hayakawa T; Kato K
J Immunol Methods; 1986 Mar; 87(2):197-201. PubMed ID: 2419451
[TBL] [Abstract][Full Text] [Related]
43. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
44. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
[TBL] [Abstract][Full Text] [Related]
45. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma.
Chen DS; Sung JL; Sheu JC; Lai MY; How SW; Hsu HC; Lee CS; Wei TC
Gastroenterology; 1984 Jun; 86(6):1404-9. PubMed ID: 6201411
[TBL] [Abstract][Full Text] [Related]
46. Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis.
Caviglia GP; Ribaldone DG; Abate ML; Ciancio A; Pellicano R; Smedile A; Saracco GM
Scand J Gastroenterol; 2018 Jun; 53(6):734-740. PubMed ID: 29667463
[TBL] [Abstract][Full Text] [Related]
47. Fucosylation of serum alpha-fetoprotein in patients with primary hepatocellular carcinoma.
Aoyagi Y; Isemura M; Yosizawa Z; Suzuki Y; Sekine C; Ono T; Ichida F
Biochim Biophys Acta; 1985 Aug; 830(3):217-23. PubMed ID: 2411292
[TBL] [Abstract][Full Text] [Related]
48. Relationship of p16 methylation status and serum alpha-fetoprotein concentration in hepatocellular carcinoma patients.
Wong IH; Lo YM; Lai PB; Johnson PJ
Clin Chem; 2000 Sep; 46(9):1420-2. PubMed ID: 10973879
[No Abstract] [Full Text] [Related]
49. Lens culinaris agglutinin-reactive α-fetoprotein decline after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma predicts survival.
Huang C; Sheng S; Sun X; Liu J; Huang G
Clin Chim Acta; 2014 Apr; 431():232-8. PubMed ID: 24565960
[TBL] [Abstract][Full Text] [Related]
50. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
51. Enzyme-linked immunosorbent assay for alpha-fetoprotein in human serum.
Chui SH; Yow CM; Lam CW; Wan KC; Lewis WH
Med Lab Sci; 1989 Oct; 46(4):305-8. PubMed ID: 2482399
[TBL] [Abstract][Full Text] [Related]
52. [Alpha-fetoprotein as a tumor marker].
Yachi A; Suga M
Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
[No Abstract] [Full Text] [Related]
53. Value of serum alpha-fetoprotein and ferritin in the diagnosis of hepatocellular carcinoma.
Tatsuta M; Yamamura H; Iishi H; Kasugai H; Okuda S
Oncology; 1986; 43(5):306-10. PubMed ID: 2429242
[TBL] [Abstract][Full Text] [Related]
54. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
[TBL] [Abstract][Full Text] [Related]
55. Elevated renin levels in patients with liver cirrhosis and hepatocellular carcinoma.
Lotfy M; El-Kenawy Ael-M; Abdel-Aziz MM; El-Kady I; Talaat A
Asian Pac J Cancer Prev; 2010; 11(5):1263-6. PubMed ID: 21198274
[TBL] [Abstract][Full Text] [Related]
56. Development of an alpha-fetoprotein and Golgi protein 73 multiplex detection assay using xMAP technology.
Wu Y; Ma J; Wang Y; Zhang Y; Hou Y; Zhang C; Sun H; Sun J; Wang Z; Li N
Clin Chim Acta; 2018 Jul; 482():209-214. PubMed ID: 29630871
[TBL] [Abstract][Full Text] [Related]
57. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Miédougé M; Salama G; Barange K; Vincent C; Vinel JP; Serre G
Clin Chim Acta; 1999 Feb; 280(1-2):161-71. PubMed ID: 10090533
[TBL] [Abstract][Full Text] [Related]
59. Immune complex transfer enzyme immunoassay for (anti-human T-cell leukemia virus type I) IgG in serum using a synthetic peptide, Cys-Gag p19(100-130), as antigen.
Kohno T; Sakoda I; Suzuki M; Izumi A; Ishikawa E
J Clin Lab Anal; 1991; 5(5):307-16. PubMed ID: 1682432
[TBL] [Abstract][Full Text] [Related]
60. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
